Evidence map›Paper›PMID 32432546›Full record

ArticleeLife2020

Translational control of one-carbon metabolism underpins ribosomal protein phenotypes in cell division and longevity.

Nairita Maitra, Chong He, Heidi M Blank, Mitsuhiro Tsuchiya, Birgit Schilling, Matt Kaeberlein, Rodolfo Aramayo, Brian K Kennedy, Michael Polymenis

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. RiboScreenInternational journal of molecular sciences · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. International journal of molecular sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Nairita MaitraDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, United States.
Chong HeBuck Institute for Research on Aging, Novato, United States.
Heidi M BlankDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, United States.
Mitsuhiro TsuchiyaDepartment of Pathology, University of Washington, Seattle, United States.
Birgit SchillingBuck Institute for Research on Aging, Novato, United States.
Matt KaeberleinDepartment of Pathology, University of Washington, Seattle, United States.ORCID 0000-0002-1311-3421
Rodolfo AramayoDepartment of Biology, Texas A&M University, College Station, United States.ORCID 0000-0001-9702-6204
Brian K KennedyBuck Institute for Research on Aging, Novato, United States.
Michael PolymenisDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, United States.ORCID 0000-0003-1507-0936
Texas A&M University · USBuck Institute for Research on Aging · USUniversity of Washington · US

Funding

SPECIFICITY OF OXYGEN DNA DAMAGE AND MUTAGENESISP01AG001751 · NIA · UNIVERSITY OF WASHINGTON · PI PRUSKY, GLEN THOMAS · 1985 to 2021
$29.6M
University of Washington Nathan Shock Center of Excellence in the Basic Biology of AgingP30AG013280 · NIA · UNIVERSITY OF WASHINGTON · PI Maitreya J Dunham · 1995 to 2026
$27.1M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Coupling Of Protein Synthesis With Cell DivisionR01GM123139 · NIGMS · TEXAS A&M AGRILIFE RESEARCH · PI POLYMENIS, MICHAEL S · 2017 to 2024
$2.9M
Orbitrap Fusion Lumos ETD with FAIMS ProS10OD028654 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI SCHILLING, BIRGIT · 2020 to 2020
$1.1M
TripleTOF 5600 High Resolution Mass SpectrometerS10OD016281 · OD · BUCK INSTITUTE FOR RESEARCH ON AGING · PI GIBSON, BRADFORD WAYNE · 2013 to 2013
$597k
NCRR NIH HHS 1S10 OD016281NIA NIH HHS P01 AG001751NIA NIH HHS P30 AG013280NIDDK NIH HHS U24 DK097154NIGMS NIH HHS R01 GM123139NIH HHS S10 OD016281NIH HHS S10 OD028654
6 · The paper itself

Abstract

A long-standing problem is how cells that lack one of the highly similar ribosomal proteins (RPs) often display distinct phenotypes. Yeast and other organisms live longer when they lack specific ribosomal proteins, especially of the large 60S subunit of the ribosome. However, longevity is neither associated with the generation time of RP deletion mutants nor with bulk inhibition of protein synthesis. Here, we queried actively dividing RP mutants through the cell cycle. Our data link transcriptional, translational, and metabolic changes to phenotypes associated with the loss of paralogous RPs. We uncovered translational control of transcripts encoding enzymes of methionine and serine metabolism, which are part of one-carbon (1C) pathways. Cells lacking Rpl22Ap, which are long-lived, have lower levels of metabolites associated with 1C metabolism. Loss of 1C enzymes increased the longevity of wild type cells. 1C pathways exist in all organisms and targeting the relevant enzymes could represent longevity interventions.

Indexed as

Gene Expression RegulationProtein BiosynthesisCarbonCell CycleCell DivisionCellular SenescenceGene LibraryLoss of Function MutationMethioninePhenotypeRibosomal ProteinsRNA-Binding ProteinsRNA, FungalRNA-SeqSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCarbonMethionineRibosomal ProteinsRNA-Binding ProteinsRNA, FungalRpl22 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSerinecell cyclechromosomesgene expressiongeneticsgenomicslongevityone-carbonribosomalRpl22S. cerevisiaetranslation

Identifiers

PMID32432546
PMCPMC7263821
OpenAlexW3027934376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.